Publicaciones en las que colabora con EVA BATANERO CREMADES (43)

2015

  1. Pollensomes as natural vehicles for pollen allergens

    Journal of Immunology, Vol. 195, Núm. 2, pp. 445-449

2014

  1. Amaranthaceae pollens: Review of an emerging allergy in the mediterranean area

    Journal of Investigational Allergology and Clinical Immunology, Vol. 24, Núm. 6, pp. 371-381

  2. Ash pollen immunoproteomics: Identification, immunologic characterization, and sequencing of 6 new allergens

    Journal of Allergy and Clinical Immunology, Vol. 133, Núm. 3

  3. Characterization of profilin and polcalcin panallergens from ash pollen

    Journal of Investigational Allergology and Clinical Immunology, Vol. 24, Núm. 4, pp. 257-266

  4. Nanovesicles are secreted during pollen germination and pollen tube growth: A possible role in fertilization

    Molecular Plant

  5. The spectrum of olive pollen allergens. From structures to diagnosis and treatment

    Methods, Vol. 66, Núm. 1, pp. 44-54

2012

  1. A non-allergenic Ole e 1-like protein from birch pollen as a tool to design hypoallergenic vaccine candidates

    Molecular Immunology, Vol. 50, Núm. 1-2, pp. 83-90

2010

  1. Bystander suppression to unrelated allergen sensitization through intranasal administration of tolerogenic exosomes in mouse

    Molecular Immunology, Vol. 47, Núm. 11-12, pp. 2148-2151

  2. Olive Pollen Allergens: An Insight into Clinical, Diagnostic and Therapeutic Concepts of Allergy

    Olives and Olive Oil in Health and Disease Prevention (Elsevier Inc.), pp. 1021-1031

2009

  1. Parallel use of CID, HCD and ETD for characterization of proteic allergens found in pollensomes

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 3, pp. 117-117

2008

  1. Exosomes from bronchoalveolar fluid of tolerized mice prevent allergic reaction

    Journal of Immunology, Vol. 181, Núm. 2, pp. 1519-1525

  2. Intranasal immunization with a dominant T-cell epitope peptide of a major allergen of olive pollen prevents mice from sensitization to the whole allergen

    Molecular Immunology, Vol. 45, Núm. 2, pp. 438-445

  3. Intranasal vaccination with poly(lactide-co-glycolide) microparticles containing a peptide T of Ole e 1 prevents mice against sensitization

    Clinical and Experimental Allergy, Vol. 38, Núm. 3, pp. 520-528

2007

  1. Emerging pollen allergens

    Biomedicine and Pharmacotherapy, Vol. 61, Núm. 1, pp. 1-7

  2. Hypoallergenic mutants of Ole e 1, the major olive pollen allergen, as candidates for allergy vaccines

    Clinical and Experimental Allergy, Vol. 37, Núm. 2, pp. 251-260

  3. Olive pollen recombinant allergens: Value in diagnosis and immunotherapy

    Journal of Investigational Allergology and Clinical Immunology, Vol. 17, Núm. SUPPL. 1, pp. 56-62

2006

  1. A recombinant functional variant of the olive pollen allergen Ole e 10 expressed in baculovirus system

    Journal of Biotechnology, Vol. 121, Núm. 3, pp. 402-409

  2. Analysis of IgE and IgG B-cell immunodominant regions of Ole e 1, the main allergen from olive pollen

    Molecular Immunology, Vol. 43, Núm. 6, pp. 570-578

  3. Prophylactic intranasal treatment with fragments of 1,3-β-glucanase olive pollen allergen prevents airway inflammation in a murine model of type I allergy

    International Archives of Allergy and Immunology, Vol. 139, Núm. 3, pp. 175-180

  4. The role of major olive pollen allergens Ole e 1, Ole e 9, and Ole e 10 on mice sensitization

    Annals of Allergy, Asthma and Immunology, Vol. 96, Núm. 3, pp. 466-471